UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000027387
Receipt No. R000031386
Scientific Title Effectiveness and Safety of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligo-synovitis Resistant to Prior TNF-alpha Inhibitors
Date of disclosure of the study information 2017/05/25
Last modified on 2021/05/21 10:48:31

No. Disposal Last modified on Item of update
1 Insert 2017/05/18 17:43:40
2 Update 2017/05/18 17:50:02 Email1
3 Update 2017/11/17 13:58:02 Other related information
4 Update 2019/05/22 17:44:45 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization2
Address2
Tel2
Email2
Organization3
Address3
Tel3
Email3
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/05/22 17:46:04 Recruitment status
Date of IRB
6 Update 2019/05/22 17:47:17 Number of participants that the trial has enrolled
7 Update 2019/11/19 12:36:35 Date of closure to data entry
8 Update 2021/05/21 10:48:31 URL releasing protocol
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.